ENTRADA THERAPEUTICS, INC. (TRDA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading TRDA…

ENTRADA THERAPEUTICS, INC. (TRDA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

ENTRADA THERAPEUTICS, INC.

TRDA · CIK 1689375

4 · Sep 3, 2026 · Chief Financial Officer WENTWORTH KORY JAMES reported 1,733 shares

4

Chief Financial Officer WENTWORTH KORY JAMES reported 1,733 shares

Filed: Sep 3, 2026
Period: Sep 2, 2026
Accession: 0001725663-26-000007
Filer: Entrada Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1788470155.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1788470155.xml
Open SEC.gov